Philip Rye, Author at AlgiPharma

This author has yet to write their bio.
Meanwhile lets just say that we are proud Philip Rye contributed a whooping 14 entries.

AlgiPharma Announces $4 Million Award from Cystic Fibrosis Foundation Therapeutics to Advance Clinical Development of OligoG

June 3, 2016 in Awards, News /by Philip Rye

AlgiPharma Announces $4 Million Award from Cystic Fibrosis Foundation Therapeutics to Advance Clinical Development of OligoG.

May 4, 2016 in News /by Philip Rye

AlgiPharma now features on the Cystic Fibrosis Foundation (CFF) drug development pipeline

March 9, 2016 in News /by Philip Rye

AlgiPharma secures new license agreement with NTNU for exclusive global rights.

February 24, 2016 in News /by Philip Rye

AlgiPharma granted Orphan Drug designation by FDA